Clinical trial Recruiting at 1 site Interventional Ages 18 and up

D-lactate test in spinal fluid for suspected ventriculostomy-related meningitis

Official title: Diagnostic Significance of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis : a Pilot Study

Run by University Hospital, Toulouse · NCT06482463 · Data updated 2026-11-12

This will test whether measuring D-lactate in cerebrospinal fluid helps diagnose meningitis in adults with an external ventriculostomy who are suspected of having a hospital-acquired infection.

More Nosocomial Infection trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment185 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedFebruary 12, 2025
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedDecember 31, 2025
Trial IDNCT06482463 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) at Toulouse University Hospital who have an external ventriculostomy and are currently suspected of having ventriculostomy-related nosocomial meningitis are eligible.

Probably not a fit

Patients with community-acquired meningitis, recent meningitis within the past month, severe renal failure or on peritoneal dialysis, short bowel syndrome, or those already diagnosed elsewhere are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center study in the neurosurgical ICU at Toulouse University Hospital collects an extra cerebrospinal fluid (CSF) sample when clinicians perform routine sampling for suspected ventriculostomy-related nosocomial meningitis. Samples are frozen at -80°C and will undergo serial assays for D‑lactate, procalcitonin (PCT), and pro-inflammatory cytokines (IL-1, IL-6, IL-8, TNFα). If the initial CSF does not meet diagnostic criteria, a second sample is taken 48–96 hours later; final clinical classification of meningitis versus no meningitis is made retrospectively by two neurosurgical intensivists using the medical record. Participants are followed through an end-of-participation visit at four weeks.

Why it matters

Potential benefit: If successful, the D‑lactate test could provide a faster and more specific CSF marker to distinguish ventriculostomy-related meningitis from noninfectious inflammation, helping guide timely antibiotic decisions.

How similar studies have gone: CSF procalcitonin and cytokine measurements have some supporting data for diagnosing nosocomial meningitis, but using D‑lactate in CSF for ventriculostomy-related meningitis is relatively novel with limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ⩾ 18 years.
* Patient with an external ventriculostomy implanted at the Toulouse University Hospital.
* Patient suspected of nosocomial meningitis due to a febrile syndrome (in the absence of any other identified infectious site), headache, nausea, lethargy, change in neurological status, meningeal syndrome, epileptic event and cutaneous or subcutaneous inflammation at the ventriculostomy site of insertion.
* Patient having expressed oral consent, after free and informed information.
* Patient affiliated to a social security scheme.

Exclusion Criteria:

* Diagnosis of community meningitis.
* Proven or suspected meningitis and/or ventriculitis during the previous month.
* Diagnosis of nosocomial meningitis made in another medical centre prior to admission.
* Short bowel syndrome.
* Acute mesenteric ischaemia.
* End-stage renal failure (GFR \< 15 ml/min/m2).
* Peritoneal dialysis.
* Patient participating in another research protocol with an exclusion period still in progress.
* Pregnant or breastfeeding woman.
* Patient under guardianship or trusteeship, persons placed under the protection of justice

Where it's running

  • Toulouse Hospital
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.